Immediate Impact

2 from Science/Nature 67 standout
Sub-graph 1 of 24

Citing Papers

Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
2024 Standout
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
2022 Standout
12 intermediate papers

Works of Rohini Chitra being referenced

Rosuvastatin improves the atherogenic and atheroprotective lipid profiles in patients with hypertriglyceridemia
2004
Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease
2003
and 3 more

Author Peers

Author Last Decade Papers Cites
Rohini Chitra 636 97 255 304 16 899
Stephen Donahue 569 63 162 274 30 1.1k
Marcella A. Evans 497 50 133 180 13 1.1k
Neil Hounslow 587 45 292 167 35 832
Bruce K. Birmingham 391 55 125 119 23 901
M.J.T.M. Mol 478 76 226 50 29 953
Sarah R. Bujac 240 48 156 36 17 900
Ripple Talati 263 33 161 63 21 759
Franco Giulianini 190 17 115 36 20 770
Minh Duong-Hua 88 65 194 47 11 852
Richard McLain 480 38 181 172 25 900

All Works

Loading papers...

Rankless by CCL
2026